Released on: September 9, 2008, 8:34 am

Press Release Author: The Scott Partnership

Industry:

Press Release Summary: (9 September, 2008) Exco InTouch (www.excointouch.com) the
leading mobile messaging provider for the pharmaceutical industry, announces that it
has partnered with US-headquartered MMG (www.mmgct.com/mmg) an international
industry leader in patient enrolment for clinical trials to enhance the efficacy of
patient recruitment and retention services for pharmaceutical sponsors.

Press Release Body: Exco InTouch Partners with MMG to Provide Effective Patient
Recruitment and Retention in Clinical Trials

(9 September, 2008) Exco InTouch (www.excointouch.com) the leading mobile messaging
provider for the pharmaceutical industry, announces that it has partnered with
US-headquartered MMG (www.mmgct.com/mmg) an international industry leader in patient
enrolment for clinical trials to enhance the efficacy of patient recruitment and
retention services for pharmaceutical sponsors. The integration of Exco InTouch\'s
REACT short messaging service
(SMS) technology will complement MMG\'s services, enhancing the company\'s ability to
quickly find good quality patients through advertising, pre-screening and selection.
Additionally, Exco InTouch\'s innovative mobile technology allows MMG to interact
directly with subjects during a clinical study, which can significantly improve
retention for faster and more cost-effective trials.

REACT SMS technology from Exco InTouch will be offered by MMG in synergy with its
existing enrolment services, enabling sponsors to quickly identify and pre-screen
potential subjects for clinical studies. The partnership between Exco InTouch and
MMG comes as a response to the demand from pharmaceutical sponsors for new and
innovative methods to find good quality, compliant volunteers for clinical trials.
Exco InTouch\'s technology complements MMG\'s existing patient communication and
recruitment services, offering SMS-based recruitment advertising and enabling fast
assessment of potential subjects\' suitability via SMS.

In addition to substantially improving patient recruitment, the new combined
services will offer significant benefits to sponsors throughout the life of the
trial. REACT produces and updates patient visit schedules, meaning that site
personnel do not need to refer to the trial protocol each time a change is made.
Customized visit and medication reminders are automatically sent to patients via
SMS, ensuring that subjects comply with the trial requirements while minimizing the
input required from study organizers.

John Benbrook, CEO of MMG, comments: \"Pharmaceutical sponsors are constantly looking
for novel ways to improve patient selection for clinical trials as well as retaining
subjects throughout the study. Adding Exco InTouch\'s innovative SMS communication
technology to our existing patient recruitment and retention services enhances our
ability to find good quality patients and to support participants throughout the
trial to ensure retention.\"

\"The new combined services from Exco InTouch and MMG reflect our close
collaboration, enabling sponsors to streamline clinical trials and offering
significant productivity gains. In addition, SMS communication between sponsors and
patients ensures that subjects feel supported throughout the trial, typically
improving retention by 20%,\" adds Tim Davis, Co-Founder of Exco InTouch.

The use of SMS technology as part of complete patient recruitment and retention
strategies will be the subject of a joint presentation by Exco InTouch and MMG at
the 4th Annual Patient Recruitment and Retention in Clinical Trials, 13-15 October,
2008, Amsterdam, Holland. Exco InTouch and MMG will co-host the half day
pre-conference workshop focusing on patient recruitment and retention strategies. To
register for this discussion, please email info@excointouch.com

For further information on the Exco InTouch portfolio of solutions, please call +44
1279 408 210 or +1 949 725 2946 or visit www.excointouch.com

For further information on MMG please call +44 (0) 1279 461708 or +1 (301)
984-7191 or visit http://www.wegetpatients.com

-ENDS-

For further press information please contact: Eleanor CallanMonk, The Scott
Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA Tel:
+44 1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com

About Exco InTouch
Exco InTouch provides secure mobile communication for healthcare and
biopharmaceutical applications improving subject recruitment, retention and
compliance during clinical trials and pharmaceutical marketing studies.

About MMG
MMG, a Ketchum (www.ketchum.com/mmg_news_release) company and part of the Omnicom
Group (NYSE:OMC) family, is the premier global patient recruitment and retention
agency. With experience across a vast range of therapeutic areas, populations and
study types in over 70 countries, MMG provides strategies which will be accepted by
study teams, ethics committees and patient populations whilst delivering the best
return on investment for the sponsor.

Web Site: http://

Contact Details: For further press information please contact: Eleanor CallanMonk,
The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA
Tel:
+44 1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com